Sentry LLC’s Pfizer PFE Stock Holding History

Sentry LLC’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$675K	Hold	28,013	–	–	0.19%	59
2026 Q1	$787K	Sell	28,013 -1,380	-5%	-$36.7K	0.25%	51
2025 Q4	$732K	Hold	29,393	–	–	0.2%	56
2025 Q3	$749K	Sell	29,393 -1,500	-5%	-$37K	0.19%	55
2025 Q2	$749K	Hold	30,893	–	–	0.15%	55
2025 Q1	$783K	Hold	30,893	–	–	0.15%	52
2024 Q4	$820K	Hold	30,893	–	–	0.16%	44
2024 Q3	$894K	Sell	30,893 -1,120	-3%	-$32.7K	0.17%	45
2024 Q2	$896K	Hold	32,013	–	–	0.17%	45
2024 Q1	$888K	Sell	32,013 -15	-0%	-$416	0.17%	47
2023 Q4	$922K	Buy	32,028 +15	+0%	+$453	0.2%	42
2023 Q3	$1.06M	Sell	32,013 -1,400	-4%	-$49.5K	0.22%	36
2023 Q2	$1.23M	Buy	33,413 +1,000	+3%	+$38.9K	0.27%	31
2023 Q1	$1.32M	Buy	+32,413	New	+$1.4M	0.31%	28

Other funds holding PFE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Sentry LLC's PFE Position: Q2 2026 in Review

Sentry LLC held its Pfizer (PFE) position steady in Q2 2026 at 28,013 shares worth $675K. The position accounts for 0.19% of the portfolio, ranked #59.

Sentry LLC first reported a position in PFE in Q1 2023 and has held it in 14 quarters since. The position peaked at $1.32M in Q1 2023. 2,822 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

Sentry LLC held 28,013 shares of Pfizer worth $675K as of Q2 2026.
Sentry LLC left its Pfizer share count unchanged in Q2 2026.
Pfizer made up 0.19% of Sentry LLC's portfolio in Q2 2026, its #59 holding.
Sentry LLC first reported a position in Pfizer in Q1 2023 and has held it in 14 quarters since.
Sentry LLC's Pfizer position peaked at $1.32M in Q1 2023.
2,822 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Sentry LLC's 13F filing for Q2 2026, filed 14 Aug 2026.